ABSTRACT

In-utero exposure to cocaine and its derivatives pose major perinatal health problems for a

large number of infants and their mothers. Since the late 1980s when cocaine and crack use

last peaked in the United States, many investigators have focused on the physical, neuro-

developmental, and neuropsychological effects of prenatal cocaine exposure on infants

and young children. Although inconclusive on many crucial issues, published studies

reveal the beginnings of a profile of possible cocaine-related effects on neuropsychological

functions subserving arousal and attention regulation. That profile is informed by

preclinical studies in which important factors such as duration and type of exposure as well

as environmental conditions may be more adequately controlled. In this chapter, we

review the state of knowledge regarding the neurobiological effects of prenatal cocaine

exposure on the developing nervous system as elaborated through use of preclinical and

clinical models. Studies in this area represent an important interface between basic studies

of normal neural ontogeny and those of neuroteratology. Because cocaine is a potent

central nervous system stimulant, understanding its effects on developing brain not only

explicates the possible neurodevelopmental impairments resulting from intrauterine

exposure to a potential neurotoxin but also sheds light on mechanisms of normal neural

ontogeny. Cocaine is also a remarkably addictive drug and hence, the adults caring for

children prenatally exposed are often themselves hindered in their parenting by their

addiction and all the associated environmental perturbations that accompany a drug-using

lifestyle. Hence, we also present a model by which the biological vulnerabilities

potentially conveyed by prenatal exposure to cocaine interact with the environmental

handicaps accompanying life in a substance dependent world. First we turn to the central

tenets of a teratological perspective.